Ko Willems van Dijk

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Chemicals & Drugs

Anatomy

Liver

Disorders

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Henneman P; Aulchenko Y S; Frants R R; van Dijk K W; Oostra B A; van Duijn C M
Prevalence and heritability of the metabolic syndrome and its individual components in a Dutch isolate: the Erasmus Rucphen Family study.
DeRuiter Marco C; Alkemade Fanneke E; Gittenberger-de Groot Adriana C; Poelmann Robert E; Havekes Louis M; van Dijk Ko Willems
Maternal transmission of risk for atherosclerosis.
Hu Lihui; van der Hoogt Caroline C; Espirito Santo Sonia M S; Out Ruud; Kypreos Kyriakos E; van Vlijmen Bart J M; Van Berkel Theo J C; Romijn Johannes A; Havekes Louis M; van Dijk Ko Willems; Rensen Patrick C N
The hepatic uptake of VLDL in lrp-ldlr-/-vldlr-/- mice is regulated by LPL activity and involves proteoglycans and SR-BI.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Ko Willems van Dijk (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Henneman P; Aulchenko Y S; Frants R R; van Dijk K W; Oostra B A; van Duijn C M
Prevalence and heritability of the metabolic syndrome and its individual components in a Dutch isolate: the Erasmus Rucphen Family study.
Journal of medical genetics 2008;45(9):572-7.
2008: DeRuiter Marco C; Alkemade Fanneke E; Gittenberger-de Groot Adriana C; Poelmann Robert E; Havekes Louis M; van Dijk Ko Willems
Maternal transmission of risk for atherosclerosis.
Current opinion in lipidology 2008;19(4):333-7.
2008: Hu Lihui; van der Hoogt Caroline C; Espirito Santo Sonia M S; Out Ruud; Kypreos Kyriakos E; van Vlijmen Bart J M; Van Berkel Theo J C; Romijn Johannes A; Havekes Louis M; van Dijk Ko Willems; Rensen Patrick C N
The hepatic uptake of VLDL in lrp-ldlr-/-vldlr-/- mice is regulated by LPL activity and involves proteoglycans and SR-BI.
Journal of lipid research 2008;49(7):1553-61.
2008: Gerritsen Gery; van der Hoogt Caroline C; Schaap Frank G; Voshol Peter J; Kypreos Kyriakos E; Maeda Nobuyo; Groen Albert K; Havekes Louis M; Rensen Patrick C N; van Dijk Ko Willems
ApoE2-associated hypertriglyceridemia is ameliorated by increased levels of apoA-V but unaffected by apoC-III deficiency.
Journal of lipid research 2008;49(5):1048-55.
2008: Hofker Marten; Bernini Franco; von Eckardstein Arnold; Freeman Dilys; Heeren Joerg; Karpe Fredrik; Kalopissis Athina; Kronenberg Florian; Kuipers Folkert; Lindstedt Ken; Parini Paolo; Schuster Gertrud; van Dijk Ko Willems
European Lipoprotein Club: Report of the 30th ELC annual conference, Tutzing, 3-6 September 2007.
Atherosclerosis 2008;197(1):471-9.
2008: Henneman P; Schaap F G; Rensen P C N; van Dijk K W; Smelt A H M
Estrogen induced hypertriglyceridemia in an apolipoprotein AV deficient patient.
Journal of internal medicine 2008;263(1):107-8.
2007: Lichtenstein Laeticia; Berbée Jimmy F P; van Dijk Susan J; van Dijk Ko Willems; Bensadoun André; Kema Ido P; Voshol Peter J; Müller Michael; Rensen Patrick C N; Kersten Sander
Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HL-dependent hepatic cholesterol uptake.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(11):2420-7.
2007: van Ginneken V; Verhey E; Poelmann R; Ramakers R; van Dijk K Willems; Ham Lisanne; Voshol P; Havekes L; Van Eck M; van der Greef J
Metabolomics (liver and blood profiling) in a mouse model in response to fasting: a study of hepatic steatosis.
Biochimica et biophysica acta 2007;1771(10):1263-70.
2007: Alkemade Fanneke E; Gittenberger-de Groot Adriana C; Schiel Anja E; VanMunsteren J Conny; Hogers Bianca; van Vliet Leontien S J; Poelmann Robert E; Havekes Louis M; Willems van Dijk Ko; DeRuiter Marco C
Intrauterine exposure to maternal atherosclerotic risk factors increases the susceptibility to atherosclerosis in adult life.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(10):2228-35.
2007: Hofker Marten; Calabresi Laura; von Eckardstein Arnold; Heeren Joerg; Karpe Fredrik; Kalopissis Athina; Kronenberg Florian; Kuipers Folkert; Lindstedt Ken; Parini Paolo; Schuster Gertrud; van Dijk Ko Willems
European Lipoprotein Club: Report of the 29th ELC Annual Conference, Tutzing, 4-7 September 2006.
Atherosclerosis 2007;193(2):461-8.
2007: Yan Daoguang; Jauhiainen Matti; Hildebrand Reeni B; Willems van Dijk Ko; Van Berkel Theo J C; Ehnholm Christian; Van Eck Miranda; Olkkonen Vesa M
Expression of human OSBP-related protein 1L in macrophages enhances atherosclerotic lesion development in LDL receptor-deficient mice.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(7):1618-24.
2007: Henneman Peter; Schaap Frank G; Havekes Louis M; Rensen Patrick C N; Frants Rune R; van Tol Arie; Hattori Hiroaki; Smelt August H M; van Dijk Ko Willems
Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.
Atherosclerosis 2007;193(1):129-34.
2007: Ferreira Valérie; van Dijk Ko Willems; Groen Albert K; Vos Rogier M; van der Kaa Jos; Gijbels Marion J J; Havekes Louis M; Pannekoek Hans
Macrophage-specific inhibition of NF-kappaB activation reduces foam-cell formation.
Atherosclerosis 2007;192(2):283-90.
2007: Krom Yvonne D; Pires Nuno M M; Jukema J Wouter; de Vries Margreet R; Frants Rune R; Havekes Louis M; van Dijk Ko Willems; Quax Paul H A
Inhibition of neointima formation by local delivery of estrogen receptor alpha and beta specific agonists.
Cardiovascular research 2007;73(1):217-26.
2006: Rip Jaap; van Dijk Ko Willems; Sierts Jeroen A; Kastelein John J P; Twisk Jaap; Kuivenhoven Jan Albert
AAV1-LPL(S447X) gene therapy reduces hypertriglyceridemia in apoE2 knock in mice.
Biochimica et biophysica acta 2006;1761(10):1163-8.
2006: Rensen Patrick C N; Gras J C Emile; Lindfors Eva K; van Dijk Ko Willems; Jukema J Wouter; van Berkel Theo J C; Biessen Erik A L
Selective targeting of liposomes to macrophages using a ligand with high affinity for the macrophage scavenger receptor class A.
Current drug discovery technologies 2006;3(2):135-44.
2006: Emile Gras J C; Verkuijlen Paul; Frants Rune R; Havekes Louis M; van Berkel Theo J C; Biessen Erik A L; van Dijk K Willems
Specific and efficient targeting of adenovirus vectors to macrophages: application of a fusion protein between an adenovirus-binding fragment and avidin, linked to a biotinylated oligonucleotide.
The journal of gene medicine 2006;8(6):668-78.
2006: van der Hoogt Caroline C; Berbée Jimmy F P; Espirito Santo Sonia M S; Gerritsen Gery; Krom Yvonne D; van der Zee André; Havekes Louis M; van Dijk Ko Willems; Rensen Patrick C N
Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in mice.
Biochimica et biophysica acta 2006;1761(2):213-20.
2006: Zadelaar Susanne M; Boesten Lianne S M; Pires Nuno M M; van Nieuwkoop Anita; Biessen Erik A L; Jukema Wouter; Havekes Louis M; van Vlijmen Bart J M; Willems van Dijk Ko
Local Cre-mediated gene recombination in vascular smooth muscle cells in mice.
Transgenic research 2006;15(1):31-6.
2006: Krom Yvonne D; Fallaux Frits J; Que Ivo; Lowik Clemens; van Dijk Ko Willems
Efficient in vivo knock-down of estrogen receptor alpha: application of recombinant adenovirus vectors for delivery of short hairpin RNA.
BMC biotechnology 2006;6():11.
2005: Rensen Patrick C N; van Dijk Ko Willems; Havekes Louis M
Apolipoprotein AV: low concentration, high impact.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(12):2445-7.
2005: Krom Y D; Gras J C E; Frants R R; Havekes L M; van Berkel T J; Biessen E A L; van Dijk K Willems
Efficient targeting of adenoviral vectors to integrin positive vascular cells utilizing a CAR-cyclic RGD linker protein.
Biochemical and biophysical research communications 2005;338(2):847-54.
2005: Eck Miranda Van; Oost Jenina; Goudriaan Jeltje R; Hoekstra Menno; Hildebrand Reeni B; Bos I Sophie T; van Dijk Ko Willems; Van Berkel Theo J C
Role of the macrophage very-low-density lipoprotein receptor in atherosclerotic lesion development.
Atherosclerosis 2005;183(2):230-7.
2005: Gerritsen Gery; Rensen Patrick C N; Kypreos Kyriakos E; Zannis Vassilis I; Havekes Louis M; Willems van Dijk Ko
ApoC-III deficiency prevents hyperlipidemia induced by apoE overexpression.
Journal of lipid research 2005;46(7):1466-73.
2005: Kypreos Kyriakos E; van Dijk Ko W; Havekes Louis M; Zannis Vassilis I
Generation of a recombinant apolipoprotein E variant with improved biological functions: hydrophobic residues (LEU-261, TRP-264, PHE-265, LEU-268, VAL-269) of apoE can account for the apoE-induced hypertriglyceridemia.
The Journal of biological chemistry 2005;280(8):6276-84.
2004: Bovenschen Niels; van Dijk Ko Willems; Havekes Louis M; Mertens Koen; van Vlijmen Bart J M
Clearance of coagulation factor VIII in very low-density lipoprotein receptor knockout mice.
British journal of haematology 2004;126(5):722-5.
2004: Goudriaan Jeltje R; Espirito Santo Sonia M S; Voshol Peter J; Teusink Bas; van Dijk Ko Willems; van Vlijmen Bart J M; Romijn Johannes A; Havekes Louis M; Rensen Patrick C N
The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis.
Journal of lipid research 2004;45(8):1475-81.
2004: Schaap Frank G; Rensen Patrick C N; Voshol Peter J; Vrins Carlos; van der Vliet Hendrik N; Chamuleau Robert A F M; Havekes Louis M; Groen Albert K; van Dijk Ko Willems
ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.
The Journal of biological chemistry 2004;279(27):27941-7.
2004: van Dijk Ko Willems; Rensen Patrick C N; Voshol Peter J; Havekes Louis M
The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?
Current opinion in lipidology 2004;15(3):239-46.
2004: Espirito Santo Sonia M S; Pires Nuno M M; Boesten Lianne S M; Gerritsen Gery; Bovenschen Niels; van Dijk Ko Willems; Jukema J Wouter; Princen Hans M G; Bensadoun André; Li Wei-Ping; Herz Joachim; Havekes Louis M; van Vlijmen Bart J M
Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol.
Blood 2004;103(10):3777-82.
2003: Kypreos Kyriakos E; Li Xiaoping; van Dijk Ko Willems; Havekes Louis M; Zannis Vassilis I
Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
Biochemistry 2003;42(33):9841-53.
2003: Gerritsen Gery; Kypreos Kyriakos E; van der Zee André; Teusink Bas; Zannis Vassilis I; Havekes Louis M; van Dijk Ko Willems
Hyperlipidemia in APOE2 transgenic mice is ameliorated by a truncated apoE variant lacking the C-terminal domain.
Journal of lipid research 2003;44(2):408-14.
2003: van Dijk Ko Willems; Kypreos Kyriakos E; d'Oliveira Christine; Fallaux Frits J
Adenovirus-mediated gene transfer.
Methods in molecular biology (Clifton, N.J.) 2003;209():231-47.
2002: Tacken Paul J; Delsing Dianne J M; Gijbels Marion J J; Quax Paul H A; Havekes Louis M; Hofker Marten H; van Dijk Ko Willems
VLDL receptor deficiency enhances intimal thickening after vascular injury but does not affect atherosclerotic lesion area.
Atherosclerosis 2002;162(1):103-10.
2001: Teusink B; Mensenkamp A R; van der Boom H; Kuipers F; van Dijk K W; Havekes L M
Stimulation of the in vivo production of very low density lipoproteins by apolipoprotein E is independent of the presence of the low density lipoprotein receptor.
The Journal of biological chemistry 2001;276(44):40693-7.
2001: Goudriaan J R; Tacken P J; Dahlmans V E; Gijbels M J; van Dijk K W; Havekes L M; Jong M C
Protection from obesity in mice lacking the VLDL receptor.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(9):1488-93.
2001: Mensenkamp A R; Teusink B; Baller J F; Wolters H; Havinga R; van Dijk K W; Havekes L M; Kuipers F
Mice expressing only the mutant APOE3Leiden gene show impaired VLDL secretion.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(8):1366-72.
2001: Kypreos K E; Teusink B; Van Dijk K W; Havekes L M; Zannis V I
Analysis of the structure and function relationship of the human apolipoprotein E in vivo, using adenovirus-mediated gene transfer.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(9):1598-600.
2001: Tacken P J; van der Zee A; Beumer T L; Florijn R J; Gijpels M J; Havekes L M; Frants R R; van Dijk K W; Hofker M H
Effective generation of very low density lipoprotein receptor transgenic mice by overlapping genomic DNA fragments: high testis expression and disturbed spermatogenesis.
Transgenic research 2001;10(3):211-21.
2001: Tacken P J; Hofker M H; Havekes L M; van Dijk K W
Living up to a name: the role of the VLDL receptor in lipid metabolism.
Current opinion in lipidology 2001;12(3):275-9.
2001: Kypreos K E; van Dijk K W; van Der Zee A; Havekes L M; Zannis V I
Domains of apolipoprotein E contributing to triglyceride and cholesterol homeostasis in vivo. Carboxyl-terminal region 203-299 promotes hepatic very low density lipoprotein-triglyceride secretion.
The Journal of biological chemistry 2001;276(23):19778-86.
2001: Kypreos K E; Morani P; van Dijk K W; Havekes L M; Zannis V I
The amino-terminal 1-185 domain of apoE promotes the clearance of lipoprotein remnants in vivo. The carboxy-terminal domain is required for induction of hyperlipidemia in normal and apoE-deficient mice.
Biochemistry 2001;40(20):6027-35.
2001: Jaari S; van Dijk K W; Olkkonen V M; van der Zee A; Metso J; Havekes L; Jauhiainen M; Ehnholm C
Dynamic changes in mouse lipoproteins induced by transiently expressed human phospholipid transfer protein (PLTP): importance of PLTP in prebeta-HDL generation.
Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology 2001;128(4):781-92.
2001: Van Eck M; Van Dijk K W; Herijgers N; Hofker M H; Groot P H; Van Berkel T J
Essential role for the (hepatic) LDL receptor in macrophage apolipoprotein E-induced reduction in serum cholesterol levels and atherosclerosis.
Atherosclerosis 2001;154(1):103-12.
2000: Tacken P J; Teusink B; Jong M C; Harats D; Havekes L M; van Dijk K W; Hofker M H
LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout mice.
Journal of lipid research 2000;41(12):2055-62.
2000: de Beer F; van Dijk K W; Jong M C; van Vark L C; van der Zee A; Hofker M H; Fallaux F J; Hoeben R C; Smelt A H; Havekes L M
Apolipoprotein E2 (Lys146-->Gln) causes hypertriglyceridemia due to an apolipoprotein E variant-specific inhibition of lipolysis of very low density lipoproteins-triglycerides.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(7):1800-6.
2000: de Winther M P; van Dijk K W; Havekes L M; Hofker M H
Macrophage scavenger receptor class A: A multifunctional receptor in atherosclerosis.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(2):290-7.
2000: Van Eck M; Herijgers N; Van Dijk K W; Havekes L M; Hofker M H; Groot P H; Van Berkel T J
Effect of macrophage-derived mouse ApoE, human ApoE3-Leiden, and human ApoE2 (Arg158-->Cys) on cholesterol levels and atherosclerosis in ApoE-deficient mice.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(1):119-27.
2000: De Winther M P; Gijbels M J; Van Dijk K W; Havekes L M; Hofker M H
Transgenic mouse models to study the role of the macrophage scavenger receptor class A in atherosclerosis.
International journal of tissue reactions 2000;22(2-3):85-91.
2000: Willems Van Dijk K; Hofker M H; Havekes L M
Use of transgenic mice to study the role of apolipoprotein E in lipid metabolism and atherosclerosis.
International journal of tissue reactions 2000;22(2-3):49-58.
1999: van Dijk K W; van Vlijmen B J; de Winther M P; van 't Hof B; van der Zee A; van der Boom H; Havekes L M; Hofker M H
Hyperlipidemia of ApoE2(Arg(158)-Cys) and ApoE3-Leiden transgenic mice is modulated predominantly by LDL receptor expression.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(12):2945-51.
1999: Mensenkamp A R; Jong M C; van Goor H; van Luyn M J; Bloks V; Havinga R; Voshol P J; Hofker M H; van Dijk K W; Havekes L M; Kuipers F
Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver.
The Journal of biological chemistry 1999;274(50):35711-8.
1999: de Winther M P; van Dijk K W; van Vlijmen B J; Gijbels M J; Heus J J; Wijers E R; van den Bos A C; Breuer M; Frants R R; Havekes L M; Hofker M H
Macrophage specific overexpression of the human macrophage scavenger receptor in transgenic mice, using a 180-kb yeast artificial chromosome, leads to enhanced foam cell formation of isolated peritoneal macrophages.
Atherosclerosis 1999;147(2):339-47.
1999: van Dijk K W; Hofker M H; Havekes L M
Dissection of the complex role of apolipoprotein E in lipoprotein metabolism and atherosclerosis using mouse models.
Current atherosclerosis reports 1999;1(2):101-7.
1999: de Winther M P; Gijbels M J; van Dijk K W; van Gorp P J; suzuki H; Kodama T; Frants R R; Havekes L M; Hofker M H
Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice.
Atherosclerosis 1999;144(2):315-21.
1999: de Bont N; Netea M G; Demacker P N; Verschueren I; Kullberg B J; van Dijk K W; van der Meer J W; Stalenhoef A F
Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection.
Journal of lipid research 1999;40(4):680-5.
1999: de Beer F; Hendriks W L; van Vark L C; Kamerling S W; van Dijk K W; Hofker M H; Smelt A H; Havekes L M
Binding of beta-VLDL to heparan sulfate proteoglycans requires lipoprotein lipase, whereas ApoE only modulates binding affinity.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(3):633-7.
1999: Jong M C; van Dijk K W; Dahlmans V E; Van der Boom H; Kobayashi K; Oka K; Siest G; Chan L; Hofker M H; Havekes L M
Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
The Biochemical journal 1999;338 ( Pt 2)():281-7.
1999: van Dijk K W; van Vlijmen B J; van't Hof H B; van der Zee A; Santamarina-Fojo S; van Berkel T J; Havekes L M; Hofker M H
In LDL receptor-deficient mice, catabolism of remnant lipoproteins requires a high level of apoE but is inhibited by excess apoE.
Journal of lipid research 1999;40(2):336-44.
1998: Ehnholm S; van Dijk K W; van 't Hof B; van der Zee A; Olkkonen V M; Jauhiainen M; Hofker M; Havekes L; Ehnholm C
Adenovirus mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice.
Journal of lipid research 1998;39(6):1248-53.
1998: van Dijk K W; van Vlijmen B J; van der Zee A; van't Hof B; van der Boom H; Kobayashi K; Chan L; Havekes L M; Hofker M H
Reversal of hypercholesterolemia in apolipoprotein E2 and apolipoprotein E3-Leiden transgenic mice by adenovirus-mediated gene transfer of the VLDL receptor.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(1):7-12.
1997: Havekes L M; van Vlijmen B J; Jong M C; van Dijk K W; Hofker M H
Use of transgenic mice in lipoprotein metabolism and atherosclerosis research.
Prostaglandins, leukotrienes, and essential fatty acids 1997;57(4-5):463-6.
1996: Jong M C; Dahlmans V E; van Gorp P J; van Dijk K W; Breuer M L; Hofker M H; Havekes L M
In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
The Journal of clinical investigation 1996;98(10):2259-67.
1996: van Vlijmen B J; van Dijk K W; van't Hof H B; van Gorp P J; van der Zee A; van der Boom H; Breuer M L; Hofker M H; Havekes L M
In the absence of endogenous mouse apolipoprotein E, apolipoprotein E*2(Arg-158 --> Cys) transgenic mice develop more severe hyperlipoproteinemia than apolipoprotein E*3-Leiden transgenic mice.
The Journal of biological chemistry 1996;271(48):30595-602.
1995: van Dijk K W; Steketee K; Havekes L; Frants R; Hofker M
Genomic and cDNA cloning of a novel mouse lipoxygenase gene.
Biochimica et biophysica acta 1995;1259(1):4-8.
1994: van der Zee A; Stas L; Hilleker C; van Leuven F; van Dijk K W; Havekes L; Frants R; Hofker M
Genomic cloning of the mouse LDL receptor related protein/alpha 2-macroglobulin receptor gene.
Genomics 1994;23(1):256-9.
1993: Sasso E H; Willems van Dijk K; Bull A P; Milner E C
A fetally expressed immunoglobulin VH1 gene belongs to a complex set of alleles.
The Journal of clinical investigation 1993;91(6):2358-67.
1993: van Dijk K W; Mortari F; Kirkham P M; Schroeder H W; Milner E C
The human immunoglobulin VH7 gene family consists of a small, polymorphic group of six to eight gene segments dispersed throughout the VH locus.
European journal of immunology 1993;23(4):832-9.
1993: van der Maarel S; van Dijk K W; Alexander C M; Sasso E H; Bull A; Milner E C
Chromosomal organization of the human VH4 gene family. Location of individual gene segments.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(7):2858-68.
1992: Willems van Dijk K; Milner L A; Sasso E H; Milner E C
Chromosomal organization of the heavy chain variable region gene segments comprising the human fetal antibody repertoire.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(21):10430-4.
1992: Weiffenbach B; Bagley R; Falls K; Hyser C; Storvick D; Jacobsen S J; Schultz P; Mendell J; Willems van Dijk K; Milner E C
Linkage analyses of five chromosome 4 markers localizes the facioscapulohumeral muscular dystrophy (FSHD) gene to distal 4q35.
American journal of human genetics 1992;51(2):416-23.
1992: Sasso E H; Willems van Dijk K; Bull A; van der Maarel S M; Milner E C
VH genes in tandem array comprise a repeated germline motif.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(4):1230-6.
1992: Van Dijk K W; Milner L A; Milner E C
Mapping of human H chain V region genes (VH4) using deletional analysis and pulsed field gel electrophoresis.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(9):2923-31.
1991: van Dijk K W; Sasso E H; Milner E C
Polymorphism of the human Ig VH4 gene family.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(10):3646-51.
1990: Sasso E H; Van Dijk K W; Milner E C
Prevalence and polymorphism of human VH3 genes.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(8):2751-7.
1989: Milner E C; Lotshaw C L; Willems van Dijk K; Charmley P; Concannon P; Schroeder H W
Isolation and mapping of a polymorphic DNA sequence pH30 on chromosome 4[HGM provisional no. D4S139]
Nucleic acids research 1989;17(10):4002.
1989: Willems van Dijk K; Schroeder H W; Perlmutter R M; Milner E C
Heterogeneity in the human Ig VH locus.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(7):2547-54.
1988: Schroeder H W; Walter M A; Hofker M H; Ebens A; Willems van Dijk K; Liao L C; Cox D W; Milner E C; Perlmutter R M
Physical linkage of a human immunoglobulin heavy chain variable region gene segment to diversity and joining region elements.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(21):8196-200.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Ko Willems van Dijk

Research Profile (preview)

Living Beings

Chemicals & Drugs

Anatomy

Disorders

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Ko Willems van Dijk (preview)

All Publications